An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  American Heart Journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.AHJ.2005.10.008PMID 16368297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thiazolidinediones, Metformin, and Outcomes in Older Patients With Diabetes and Heart Failure: An Observational Study

  2005cited by this paper
• Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

  2005cited by this paper
• Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure.

  2004cited by this paper
• The incidence of congestive heart failure in type 2 diabetes: an update.

  2004cited by this paper
• Effects of diabetes mellitus and ischemic heart disease on the progression from asymptomatic left ventricular dysfunction to symptomatic heart failure: a retrospective analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Prevention trial.

  2004cited by this paper
• Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure.

  2004cited by this paper
• The adult patient with native coarctation of the aorta: balloon angioplasty or primary stenting?

  2003cited by this paper
• Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity.

  2003cited by this paper
• Demographics and concomitant disorders in heart failure.

  2003cited by this paper
• The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial.

  2003cited by this paper
• Functional class in patients with heart failure is associated with the development of diabetes.

  2003cited by this paper
• Mode of death in heart failure: findings from the ATLAS trial

  2003cited by this paper
• The relationship between cholesterol and survival in patients with chronic heart failure.

  2003cited by this paper
• Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure.

  2002cited by this paper
• The impact of obesity on survival in patients with heart failure.

  2002cited by this paper
• Clinical features and outcomes of elderly outpatients with heart failure followed up in hospital cardiology units: data from a large nationwide cardiology database (IN-CHF Registry).

  2002cited by this paper
• Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.

  2002cited by this paper
• The prognostic value of body mass index and standard exercise testing in male veterans with congestive heart failure.

  2002cited by this paper
• The relationship between obesity and mortality in patients with heart failure.

  2001cited by this paper
• Glycemic Control and Heart Failure Among Adult Patients With Diabetes

  2001cited by this paper
• Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.

  2001cited by this paper
• Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction.

  2001cited by this paper
• The prognosis of heart failure in the general population: The Rotterdam Study.

  2001cited by this paper
• Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors.

  2001cited by this paper
• Mortality remains high for outpatient transplant candidates with prolonged (>6 months) waiting list time.

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure.

  1997cited by this paper
• Wasting as independent risk factor for mortality in chronic heart failure.

  1997cited by this paper
• Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.

  1997cited by this paper
• Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system.

  1996cited by this paper
• Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry.

  1996cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• The epidemiology of heart failure: the Framingham Study.

  1993cited by this paper
• Diabetes and cardiovascular disease. The Framingham study.

  1979cited by this paper
• Role of diabetes in congestive heart failure: the Framingham study.

  1974cited by this paper

• The Dual Impact of Obesity and Diabetes on Heart Failure Readmissions: Results from the Congestive Heart Failure Registry at Harlem Hospital Center

  2025cites this paper
• Association between Hemoglobin Glycation Index and In-Hospital all-cause mortality of patients with Congestive Heart Failure: a retrospective study utilizing the MIMIC-IV database

  2025cites this paper
• Association between the haemoglobin glycation index (HGI) and clinical outcomes in patients with acute decompensated heart failure

  2024cites this paper
• Transition probabilities of diabetic retinopathy and death in an Asian population with Diabetes.

  2024cites this paper
• Research Progress on the Relationship between HbA1c and Diabetes Complicated with Chronic Heart Failure

  2024cites this paper
• Intensified glycemic control by HbA1c for patients with coronary heart disease and Type 2 diabetes: a review of findings and conclusions

  2023cites this paper
• Treatment of type 2 diabetes patients with heart conditions

  2023cites this paper
• Circulating metabolic signatures of heart failure in precision cardiology

  2023cites this paper
• Impact of insulin therapy on outcomes of diabetic patients with heart failure: A systematic review and meta-analysis

  2022cites this paper
• HbA1c level is associated with the development of heart failure with recovered ejection fraction in hospitalized heart failure patients with type 2 diabetes.

  2022cites this paper
• Association between nitrated lipoproteins and vascular function in type 2 diabetes.

  2021cites this paper
• Diabetes Management in Patients with Heart Failure

  2021cites this paper
• Medication Self-efficacy and Its Related Factors: A Cross-sectional Study on Patients with Coronary Artery Disease in North East of Iran

  2021cites this paper
• Which drug is best for a patient with type 2 diabetes and heart failure?

  2021cites this paper
• Intersection Between Diabetes and Heart Failure: Is SGLT2i the “One Stone for Two Birds” Approach?

  2021cites this paper
• Prognostic Implication of Admission HbA1c for All-cause Mortality in Ischemic Heart Failure Among a Chinese Population: A Prospective Cohort Study

  2021cites this paper
• Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence

  2020cites this paper
• MANAGEMENT OF HEART FAILURE IN PATIENTS WITH DIABETES MELLITUS : A REVIEW

  2019cites this paper
• Association of glycemic variability with left ventricular diastolic function in type 2 diabetes mellitus

  2019cites this paper
• Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America.

  2019cites this paper
• Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America.

  2019cites this paper
• Elevated Glycemic Gap Predicts Acute Respiratory Failure and In-hospital Mortality in Acute Heart Failure Patients with Diabetes

  2019cites this paper
• Comparative outcomes of heart failure among existent classes of anti-diabetic agents: a network meta-analysis of 171,253 participants from 91 randomized controlled trials

  2019cites this paper
• Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose‐lowering medications

  2019cites this paper
• Glycated Hemoglobin and Outcomes of Heart Failure (from Get With the Guidelines-Heart Failure).

  2019cites this paper
• Diabetic cardiomyopathy: factual or factoid?

  2019cites this paper
• Title: Association between type 2 diabetes and all-cause hospitalization and mortality in the UK general heart failure population: stratification by diabetic glycemic control and medication intensification

  2019cites this paper
• Efficacy of sodium-glucose co-transporter 2 inhibitors in patients with type II diabetes

  2019cites this paper
• Physiological monitoring of the complex multimorbid heart failure patient – diabetes and monitoring glucose control

  2019cites this paper
• European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure

  2019cites this paper
• A Review of Cardiovascular Outcomes Trials of Glucose-Lowering Therapies and Their Effects on Heart Failure Outcomes.

  2019cites this paper
• Clinical aspects of heart failure in individuals with diabetes

  2019cites this paper
• Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus

  2018cites this paper
• Heart Failure: Epidemiology, Pathophysiology, and Management of Heart Failure in Diabetes Mellitus.

  2018cites this paper
• Higher mortality rate in patients with heart failure who are taking commonly prescribed antidiabetic medications and achieve recommended levels of glycaemic control

  2018cites this paper
• Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology

  2018cites this paper
• 2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases

  2018cites this paper
• Effects of glycemic control on in-hospital mortality among acute heart failure patients with reduced, mid-range, and preserved ejection fraction

  2018cites this paper
• Effect of glucose-lowering therapies on heart failure

  2018cites this paper
• Heart Failure With Preserved Ejection Fraction in Diabetes: Mechanisms and Management.

  2018cites this paper
• A study of thyroid dysfunction and its associated risk factors among type 2 diabetes mellitus patients

  2018cites this paper
• Revisiting the Diabetes-Heart Failure Connection

  2018cites this paper
• Routine use of HbA1c amongst inpatients hospitalised with decompensated heart failure and the association of dysglycaemia with outcomes

  2018cites this paper
• Treatment of Diabetes in Patients with Heart Failure

  2018cites this paper
• Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification.

  2018cites this paper
• Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices: A Single Institutional 9-Year Experience

  2017cites this paper
• Safety of diabetes drugs in patients with heart failure.

  2017cites this paper
• Dose Modification of Antidiabetic Agents in Patients with Type 2 Diabetes Mellitus and Heart Failure

  2017cites this paper
• Higher hemoglobin A1c levels are associated with impaired left ventricular diastolic function and higher incidence of adverse cardiac events in patients with nonischemic dilated cardiomyopathy

  2017cites this paper
• Safety of diabetes drugs in patients with heart failure.

  2017cites this paper
• Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes

  2017cites this paper
• Treating Disease Mechanisms in Patients With Heart Failure and Diabetes Mellitus

  2017cites this paper
• The need for re‐defining cut‐off values in heart failure: From obesity to iron deficiency

  2017cites this paper
• Glycemic variability during algorithmic titration of insulin among hospitalized patients with type 2 diabetes and heart failure.

  2016cites this paper
• Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.

  2016cites this paper
• Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation.

  2016influential citation
• Effect of tighter glycemic control on cardiac function, exercise capacity, and muscle strength in heart failure patients with type 2 diabetes: a randomized study

  2016cites this paper
• Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study

  2016cites this paper
• Association of HbA1c with hospitalization and mortality among patients with heart failure and diabetes

  2016cites this paper
• Prevalent Diabetes Mellitus: Mortality and Management in Norwegian Heart Failure Outpatients

  2016cites this paper
• Insulin treatment may not be associated with worse prognosis in acute heart failure diabetic patients.

  2016cites this paper
• Herzinsuffizienz bei Diabetes vorbeugen und entgegenwirken

  2016cites this paper
• Heart failure in diabetes: effects of anti-hyperglycemic drug therapy

  2016cites this paper
• Do we need a Wider Therapeutic Paradigm for Heart Failure with Comorbidities? - A Remote Australian Perspective

  2016cites this paper
• Assessing Risks of Glucose Lowering Therapy in Heart Failure: Should We Rely on Post-hoc Analyses?

  2016cites this paper
• Insuficiencia cardiaca y diabetes mellitus en pacientes ingresados en el Hospital Universitario “Comandante Manuel Fajardo”

  2016cites this paper
• Clinical Investigation Outcomes for Patients With Diabetes After Continuous-Flow Left Ventricular Assist Device Implantation

  2016cites this paper
• Heart failure and diabetes mellitus found in hospitalized patients in “Comandante Manuel Fajardo” university hospital

  2016cites this paper
• Contributory risk and Management of Comorbidities of Hypertension, obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure

  2016cites this paper
• Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy.

  2015cites this paper
• Insulin and the cellular death

  2015cites this paper
• Efecto diferencial de la glucohemoglobina y el tratamiento antidiabético sobre el riesgo de reingreso a 30 días después de un ingreso por insuficiencia cardiaca aguda

  2015cites this paper
• Glycosylated haemoglobin is associated with neurohormonal activation and poor outcome in chronic heart failure patients with mild left ventricular systolic dysfunction

  2015cites this paper
• Differential Effect of Glycosylated Hemoglobin Value and Antidiabetic Treatment on the Risk of 30-day Readmission Following a Hospitalization for Acute Heart Failure.

  2015cites this paper
• The Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart Failure

  2015cites this paper
• Concomitant diabetes mellitus and heart failure.

  2015cites this paper
• Relationship of Glycated Hemoglobin Levels with Myocardial Injury following Elective Percutaneous Coronary Intervention in Patients with Type 2 Diabetes Mellitus

  2014cites this paper
• Facteurs associés au mauvais contrôle glycémique dans une population de diabétiques de type 2 de l’Afrique Sub-saharienne

  2014cites this paper
• Glycosylated Haemoglobin (HbA1c) - A Marker of Circulating Lipids in Type 2 Diabetic Patients.

  2014cites this paper
• Hemoglobin A1c, comorbid conditions and all-cause mortality in older patients with diabetes: a retrospective 9-year cohort study.

  2014cites this paper
• Glycemic Variability in Hospitalized Patients: Choosing Metrics While Awaiting the Evidence

  2013cites this paper
• U-shape association between hemoglobin A1c and late mortality in patients with heart failure after cardiac surgery.

  2013cites this paper
• Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach.

  2013cites this paper
• Insulin resistance, chronic heart failure and potential treatment

  2013cites this paper
• Impact of new-onset diabetes mellitus and glycemic control on the prognosis of heart failure patients: a propensity-matched study in the community.

  2013cites this paper
• EFFECTS OF GRISEOFULVIN ON SOME BIOCHEMICAL PARAMETERS OF WISTAR ALBINO RATS

  2013cites this paper
• Pharmacological modulation of insulin resistance : benefits and harms

  2013cites this paper
• Cardiogenic diabetes

  2013influential citation
• The U-shaped Relationship of Traditional Cardiovascular Risk Factors and Adverse Outcomes in Later Life.

  2012cites this paper
• A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death

  2012cites this paper
• A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy: A Matter of Life or Death

  2012cites this paper
• Congestive Heart Failure and Diabetes: Balancing Glycemic Control with Heart Failure Improvement

  2012cites this paper
• After avandia: the use of antidiabetic drugs in patients with heart failure.

  2012cites this paper
• Comorbid Heart Failure and Renal Impairment: Epidemiology and Management

  2012cites this paper
• Title A Critical Evaluation of Glycated Protein Parameters in Advanced Nephropathy : A Matter of Life or Death . A 1 C remains the gold standard outcome predictor in diabetic dialysis patients

  2012cites this paper
• Investigating the Correlation between HbA1c with Monthly Mortality and Morbidity of ST Elevation Myocardial Infarction

  2012cites this paper
• Diabetic cardiomyopathy and diastolic heart failure -- difficulties with relaxation.

  2012cites this paper
• Relation between hemoglobin a(1c) and outcomes in heart failure patients with and without diabetes mellitus.

  2012cites this paper
• Glycaemic Control & Heart Failure Development Importance of Health Promotion in the Diabetic Patient

  2012cites this paper
• The Use of Antidiabetic Drugs in Patients with Heart Failure

  2012cites this paper